MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31, IKT has $181,204,516 in assets. $8,300,837 in debts.

Balance Sheets Overview

Current Ratio
2169.77%
Quick Ratio
2169.77%
Debt to Asset Ratio
4.58%
Unit: Dollar
Assets Breakdown
    • Cash and cash equivalents
    • Marketable securities
    • Prepaid research and development
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Contingent consideration liabili...
    • Others

Balance Sheets
2025-12-31
Cash and cash equivalents
139,220,208
Marketable securities
39,543,820
Prepaid research and development
1,001,993
Prepaid expenses and other current assets
343,374
Total current assets
180,109,395
Equipment and improvements, net
0
Right-of-use asset
0
Prepaid research and development, noncurrent
1,000,000
Amount held as a retainer
95,121
Total assets
181,204,516
Accounts payable
1,158,054
Lease obligation, current
0
Accrued expenses and other current liabilities
4,081,282
Contingent consideration liability
3,061,501
Total current liabilities
8,300,837
Total liabilities
8,300,837
Common stock, 0.001 par value 500,000,000 and 100,000,000 shares authorized 131,691,237 and 69,362,439 shares issued and outstanding (including 4,149,252 and 0 contingently issuable shares - see note 7) at december 31, 2025 and december 31, 2024, respectively
131,691
Additional paid-in capital
315,429,986
Accumulated other comprehensive income (loss)
21,802
Accumulated deficit
-142,679,800
Total stockholders' equity
172,903,679
Total liabilities and stockholders' equity
181,204,516
Unit: Dollar.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$139,220,208 Marketable securities$39,543,820 Prepaid research anddevelopment$1,001,993 Prepaid expenses andother current assets$343,374 Total current assets$180,109,395 Prepaid research anddevelopment, noncurrent$1,000,000 Amount held as aretainer$95,121 Total assets$181,204,516 Total liabilities andstockholders' equity$181,204,516 Total stockholders'equity$172,903,679 Total liabilities$8,300,837 Accumulated deficit-$142,679,800 Additional paid-in capital$315,429,986 Total currentliabilities$8,300,837 Common stock, 0.001 parvalue 500,000,000 and...$131,691 Accumulated othercomprehensive income (loss)$21,802 Accrued expenses andother current...$4,081,282 Contingent considerationliability$3,061,501 Accounts payable$1,158,054

Inhibikase Therapeutics, Inc. (IKT)

Inhibikase Therapeutics, Inc. (IKT)